Chemotherapy-induced changes of CA 125 in patients with epithelial ovarian cancer
- 31 May 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (2) , 410-412
- https://doi.org/10.1016/j.ygyno.2005.02.003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian CancerGynecologic Oncology, 2000
- Serum CA 125 levels and survival in advanced ovarian cancerArchiv für Gynäkologie, 1997
- Prognostic indicators for poor risk epithelial ovarian carcinomaCancer, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Prognostic value of CA 125 in advanced ovarian cancerGynecologic Oncology, 1992
- Droloxifene-Induced Spikes of Tumor Markers Predict Benefit of TherapyAmerican Journal of Clinical Oncology, 1991
- Predictive value of CA 125 during early chemotherapy of advanced ovarian cancerGynecologic Oncology, 1990
- CA 125 in the diagnosis of pelvic massesEuropean Journal of Cancer and Clinical Oncology, 1989
- Predictive factors for long-term survival in patients with advanced ovarian cancerGynecologic Oncology, 1989
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980